Medicare to offer free CBD to select patients under new Trump administration program
Crypto Briefing
The Trump administration launched a pilot program providing free, hemp-derived CBD to eligible Medicare beneficiaries following a Schedule III cannabis reclassification.Summary
The Trump administration has introduced a pilot program through the Centers for Medicare & Medicaid Services that offers eligible Medicare Advantage enrollees free, hemp-derived CBD products with a physician's recommendation. This initiative follows the executive reclassification of marijuana to a Schedule III substance, signaling a shift in federal policy regarding cannabis for medical use. While the program aims to track clinical outcomes, it also highlights potential impacts on cannabis banking, the broader pharmaceutical industry, and the role of blockchain in managing large-scale health data. However, the program remains subject to potential future policy reversals or administrative changes.
(Source：Crypto Briefing)